Idexx Laboratories (IDXX) Non-Current Debt (2016 - 2025)
Historic Non-Current Debt for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $374.8 million.
- Idexx Laboratories' Non-Current Debt fell 2857.18% to $374.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $374.8 million, marking a year-over-year decrease of 2857.18%. This contributed to the annual value of $449.8 million for FY2024, which is 2778.96% down from last year.
- According to the latest figures from Q3 2025, Idexx Laboratories' Non-Current Debt is $374.8 million, which was down 2857.18% from $449.8 million recorded in Q2 2025.
- In the past 5 years, Idexx Laboratories' Non-Current Debt ranged from a high of $780.1 million in Q2 2021 and a low of $374.8 million during Q3 2025
- Moreover, its 5-year median value for Non-Current Debt was $694.4 million (2022), whereas its average is $638.8 million.
- As far as peak fluctuations go, Idexx Laboratories' Non-Current Debt skyrocketed by 1167.02% in 2021, and later tumbled by 2857.18% in 2025.
- Idexx Laboratories' Non-Current Debt (Quarter) stood at $775.2 million in 2021, then decreased by 10.43% to $694.4 million in 2022, then dropped by 10.3% to $622.9 million in 2023, then fell by 27.79% to $449.8 million in 2024, then decreased by 16.67% to $374.8 million in 2025.
- Its Non-Current Debt was $374.8 million in Q3 2025, compared to $449.8 million in Q2 2025 and $449.8 million in Q1 2025.